What Has Been the Growth of the Anticoccidial Drugs Market So Far?
The anticoccidial drugs market has seen considerable growth due to a variety of factors.
• The anticoccidial drugs market has experienced notable growth in recent years. It is expected to grow from $1.27 billion in 2024 to $1.37 billion in 2025, at a compound annual growth rate (CAGR) of 7.6%.
This growth is attributed to the rising incidence of coccidiosis globally, an increase in pet ownership, the widespread prevalence of coccidiosis, its economic impact, and heightened safety concerns regarding food and animal health.
What Are the Future Growth Projections for the Anticoccidial Drugs Market?
The anticoccidial drugs market is expected to maintain its strong growth trajectory in upcoming years.
• The anticoccidial drugs market is expected to grow rapidly, reaching $1.81 billion by 2029 with a CAGR of 7.2%.
Factors driving this growth include increasing veterinary healthcare, the rise in coccidiosis among animals, growing demand for synthetic drugs, feed additives, and higher livestock production. Trends include higher demand due to emerging coccidiosis strains, a shift to natural treatments, innovation prompted by regulatory scrutiny, rising demand for antibiotic-free poultry, advancements in drug delivery, and growing use in aquaculture and companion animals.
What Are The Core Factors Supporting Growth In The Anticoccidial Drugs Market?
The growing demand for meat proteins is expected to drive the growth of the anticoccidial drug market. The rising demand for meat proteins, driven by population growth, increasing disposable income, urbanization, and dietary changes, requires efficient and sustainable farming methods. Anticoccidial drugs are used in livestock farming to maintain animal health and productivity, preventing diseases like coccidiosis. In 2022, global meat prices surged by 10%, reflecting the increased demand for meat proteins, which is driving the growth of the anticoccidial drug market.
What Are The Major Segments Within The Global Anticoccidial Drugs Market?
The anticoccidial drugs market covered in this report is segmented –
1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine
Pre-Book The Anticoccidial Drugs Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Anticoccidial Drugs Market?
Companies in the anticoccidial drugs market are introducing new solutions, such as synthetic coccidiostat, to combat coccidiosis in poultry. For instance, in March 2023, Zoetis launched Avi-Deccox, a reformulated synthetic coccidiostat designed to effectively control coccidiosis in broiler chickens. It addresses resistance issues associated with ionophores and targets specific pathogens responsible for economic losses in poultry farming.
Who Are the Key Players In The Anticoccidial Drugs Market?
Major companies operating in the anticoccidial drugs market are:
• Johnson & Johnson
• Merck and Co. Inc.
• Bayer AG
• Novartis AG
• Eli Lilly and Company Ltd.
• Boehringer Ingelheim GmbH
• Zoetis Inc.
• Elanco Animal Health Incorporated
• Intas Pharmaceuticals Ltd.
• Ceva Santé Animale S.A.
• Virbac S.A.
• Phibro Animal Health Corporation
• Vetoquinol SA
• Alpharma BVBA
• Kepro B.V.
• Kemin Industries Inc.
• Tianjin Ringpu Bio-Technology Co. Ltd.
• Hester Biosciences Limited
• Huvepharma AD
• Biovet S.A.
• Lallemand Animal Nutrition
• HIPRA
• Impextraco NV
• Venkateshwara Hatcheries Pvt Ltd
What Is The Most Dominant Region In The Anticoccidial Drugs Market?
North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
